Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.
NCT02417831 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2020-04-27
Summary
A bio-equivalence of 2 different capsule formulations in fasted subjects
Conditions
- Prostatic Hyperplasia
Interventions
- DRUG
-
tamsulosin capsules
- DRUG
-
tamsulosin HCl
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
More Related Trials
-
Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
NCT02245555 ·Status: COMPLETED
-
Actual Use Study of Tamsulosin in Men
NCT02573311 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
NCT02184585 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
NCT02509104 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia
NCT02244242 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers
NCT02264184 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence - Duodart Against Avodart & Omnic
NCT01657851 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.
NCT01254071 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State
NCT02058576 ·Status: COMPLETED ·Phase: PHASE1
-
Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions
NCT01149733 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers
NCT02264171 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation
NCT02180789 ·Status: COMPLETED ·Phase: PHASE4
-
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
NCT00090103 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study
NCT05818670 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
NCT02244320 ·Status: COMPLETED
-
Intermittent vs Daily Tamsulosin for LUTS/BPH
NCT07308002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
NCT01726270 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
NCT02862483 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study
NCT06809205 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
NCT00237536 ·Status: TERMINATED ·Phase: PHASE2
-
FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia
NCT02244255 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms
NCT01021332 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia
NCT02827578 ·Status: UNKNOWN ·Phase: PHASE3
-
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
NCT00701779 ·Status: COMPLETED ·Phase: PHASE4
-
(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
NCT05236634 ·Status: UNKNOWN ·Phase: NA